Načítá se...
Nanomedicine in Oncocardiology: Contribution and Perspectives of Preclinical Studies
Cancer and cardiovascular diseases are the leading causes of death and morbidity worldwide. Strikingly, cardiovascular disorders are more common and more severe in cancer patients than in the general population, increasing incidence rates. In this context, it is vital to consider the anticancer effi...
Uloženo v:
| Vydáno v: | Front Cardiovasc Med |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Frontiers Media S.A.
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8277942/ https://ncbi.nlm.nih.gov/pubmed/34277738 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcvm.2021.690533 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|